Ivaylo Ivanhoff's Opinion & Analysis
A complete archive of Ivaylo Ivanhoff's articles, including current analysis & opinion - Page 8
Recent Chinese IPOs have gone wild. Many of them have doubled in a month or two. Highly-shorted stocks are forcing short sellers out of their positions. Many momentum tech stocks are looking...
Many biotech stocks don’t trade on earnings (they don’t have any) but on expectations for future earnings potential. With ASCO right around the corner, we are starting to see some biotech...
The recent rally in interest rates is redrawing the market map. While emerging markets and high-yield stocks are struggling, the US Small Cap Index broke out to new all-time highs. We continue to...
Charts in this post are powered by MarketSmith.Being up when almost everything is up is not a big deal. But being up when the majority of the market is down is something to pay attention to. This is...
One piece of anecdotal evidence that the U.S. economy is booming and consumer confidence is near all-time highs is the price action in Malibu Boats (NASDAQ:MBUU), which makes sports boats.I’ve...
The stocks below have a very high short interest – over 20% of their float. They are close to their 52-week highs and have built a small base, which might turn into a launching pad for higher...
Five and a half years ago, Abnormal Returns asked a bunch of people from the financial blogosphere to share their best pick for the next decade – an asset people would feel comfortable holding....
The number of publicly traded companies has been halved in the past twenty or so years – from about 7000 in 1997 to about 3,500 today. The Internet boom brought many small companies to life in...
Some technical purists claim it is wrong to look at a weekly chart before the week has been completed. For example, you should not be looking at weekly charts on a Tuesday and make your decision based...
After spending the last five months going nowhere, Ctripcom International Ltd (NASDAQ:CTRP), Priceline.com Incorporated (NASDAQ:PCLN), and Expedia Inc (NASDAQ:EXPE) are trying to retake their 50-day...